glp 1 agonist liraglutide is a GLP-1 Receptor for Type 2 Diabetes Research GLP-1 Agonists: A Comprehensive Overview

Challenges in studies of GLP-1 and in development of GLP-1R agonists In the era of rapid daily progress in biomedical science, it is surprising that it took almost 20 years from identification of GLP-1 to successful approval of the worlds first clinically utilized GLP-1R agonist

These policies promote the use of GLP-1 analogs to treat more people, increasing accessibility

The review also notes that GLP-1 medicines reduce complications in conditions such as obstructive sleep apnea (OSA), expanding their cardiometabolic relevance

INTRODUCTION Studies using surrogate markers of CVD risks Hypertension affects almost three-quarters of T2D patients [29] and is a powerful independent predictor of CVD mortality [30]